Schedule 13G ownership disclosure

CELLECTAR BIOSCIENCES INC

Security class unavailable · CUSIP: 15117F500

Event date: 2024-06-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,709,516
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001622627-24-000039
Form type
SC 13G
Filer
Cellectar Biosciences, Inc.
CIK
CIK 1279704
Filed
Jul 11, 2024
Reporting period
Jun 28, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub